Aptamers targeting cancer-associated proteins such as nucleolin, mucin 1, and prostate-specific membrane antigen have been conjugated to various types of nanoparticles, demonstrating selective cancer cell binding and internalization [47], suggesting potential applications for eco-AgNP conjugation. Here, MUC1 is linked to cancer.